Design, SAR, Angiogenic Activities Evaluation and Pro-Angiogenic Mechanism of New Marine Cyclopeptide Analogs
Authors: Li, J.; Lu, X.; Wu, Q.; Yu, G.; Xu, Z.; Qiu, L.; Pei, Z.; Lin, Y.; Pang, J.
Source: Current Medicinal Chemistry, Volume 20, Number 9, March 2013 , pp. 1183-1194(12)
Publisher: Bentham Science Publishers
Abstract:Angiogenesis plays an important role in a wide range of physiological processes. In this paper, we designed and synthesized a series of new analogs including 11 line-peptides and 9 cyclo-peptides by using a marine cyclopeptide (compound 21) which could stimulate angiogenesis on zebrafish in our previous studies as lead compound. The majority of compounds synthesized exhibited angiogenic effects when tested in vivo on zebrafish. Among them, compounds 3, 4, 10, and 15 exhibited much stronger angiogenic activities on zebrafish compared with the lead compound, and the line peptides 3 and 4 showed the most significant angiogenic activities. The SAR (structure-activity relationship) analysis revealed that Val, Lys and Ala are important for the activity. Further studies showed that 3 could concentration-dependently stimulate proliferation, migration and invasion in HUVECs (human umbilical vein endothelial cells) in vitro. To explore the angiogenesis mechanism of this series of compounds, a microarray analysis was carried out to study the gene expression profile and the result showed that 26 genes were upregulated more than 2 fold changes in treatment with 3 on zebrafish, in which mmp9 and mmp13a, two angiogenesis-related genes, increased up to 5-folds. Moreover, through the GO (gene ontology) enrichment analysis, mmp9 and mmp13a genes are the central nodes in the biological processes network. These results suggested that the pro-angiogenic mechanism of this kind of small molecular peptides is related with the expression and regulation of mmp genes in the signal transduction pathways. Additionally, one mmp inhibitor was chosen for further confirmation.
Keywords: Angiogenesis; angiogenic activity; cyclopeptide; gene ontology; human umbilical vein endothelial cells; microarray analysis; mmp; pro-angiogenic mechanism; structure-activity relationship; zebrafish
Document Type: Research Article
Publication date: March 1, 2013
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.